BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34625636)

  • 21. Risk of malignancy according to sub-classification of the atypia of undetermined significance or follicular lesion of undetermined significance (AUS/FLUS) category in the Bethesda system for reporting thyroid cytopathology.
    Kim SJ; Roh J; Baek JH; Hong SJ; Shong YK; Kim WB; Song DE
    Cytopathology; 2017 Feb; 28(1):65-73. PubMed ID: 27245883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of repeat fine-needle aspiration in thyroid nodules categorized as atypia of undetermined significance or follicular lesion of undetermined significance: A single center experience.
    Marin F; Murillo R; Diego C; Jodar E; Acevedo A
    Diagn Cytopathol; 2021 Mar; 49(3):412-417. PubMed ID: 33252841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prediction of malignant risk in the category "atypia of undetermined significance/follicular lesion of undetermined significance" of the Bethesda System for Reporting Thyroid Cytopathology using subcategorization and BRAF mutation results.
    Hyeon J; Ahn S; Shin JH; Oh YL
    Cancer Cytopathol; 2014 May; 122(5):368-76. PubMed ID: 24591408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thyroid cytology in Pakistan: An institutional audit of the atypia of undetermined significance/follicular lesion of undetermined significance category.
    Fatima S; Qureshi R; Imran S; Idrees R; Ahmad Z; Kayani N; Ahmed A
    Cytopathology; 2021 Mar; 32(2):205-210. PubMed ID: 33098589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome of atypia of undetermined significance/follicular lesion of undetermined significance in thyroid fine-needle aspirations: A six-year institutional experience.
    Xu XM; Angelova E; Clement CG
    Diagn Cytopathol; 2021 Aug; 49(8):915-920. PubMed ID: 33973739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Qualifiers of atypia in the cytologic diagnosis of thyroid nodules are associated with different Afirma gene expression classifier results and clinical outcomes.
    Baca SC; Wong KS; Strickland KC; Heller HT; Kim MI; Barletta JA; Cibas ES; Krane JF; Marqusee E; Angell TE
    Cancer Cytopathol; 2017 May; 125(5):313-322. PubMed ID: 28152275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytology-Ultrasonography Risk-Stratification Scoring System Based on Fine-Needle Aspiration Cytology and the Korean-Thyroid Imaging Reporting and Data System.
    Hong MJ; Na DG; Baek JH; Sung JY; Kim JH
    Thyroid; 2017 Jul; 27(7):953-959. PubMed ID: 28463597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thyroid cancer detection rate and associated risk factors in patients with thyroid nodules classified as Bethesda category III.
    Mileva M; Stoilovska B; Jovanovska A; Ugrinska A; Petrushevska G; Kostadinova-Kunovska S; Miladinova D; Majstorov V
    Radiol Oncol; 2018 Sep; 52(4):370-376. PubMed ID: 30265655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low Malignancy Rates in Fine-Needle Aspiration Cytologies in a Primary Care Setting in Germany.
    Eszlinger M; Ullmann M; Ruschenburg I; Böhme K; Görke F; Franzius C; Adam S; Molwitz T; Landvogt C; Amro B; Hach A; Feldmann B; Graf D; Wefer A; Niemann R; Bullmann C; Klaushenke G; Santen R; Tönshoff G; Ivancevic V; Kögler A; Bell E; Lorenz B; Kluge G; Hartenstein C; Paschke R
    Thyroid; 2017 Nov; 27(11):1385-1392. PubMed ID: 28982301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malignancy Rate of Bethesda Class III Thyroid Nodules Based on the Presence of Chronic Lymphocytic Thyroiditis in Surgical Patients.
    Cho YY; Chung YJ; Kim HS
    Front Endocrinol (Lausanne); 2021; 12():745395. PubMed ID: 34659127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High risk of malignancy in cases with atypia of undetermined significance on fine needle aspiration of thyroid nodules even after exclusion of NIFTP.
    Özkara SK; Bayrak BY; Turan G
    Diagn Cytopathol; 2020 Nov; 48(11):986-997. PubMed ID: 32745375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fine-needle aspiration cytology repetition in thyroid nodules with non-diagnostic findings or atypia of undetermined significance/follicular lesions of undetermined significance: Does time matters?
    Benido Silva V; Borges Duarte D; Teresa Pereira M; Couto de Carvalho A; Freitas C
    Ann Endocrinol (Paris); 2022 Aug; 83(4):232-236. PubMed ID: 35489413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Bethesda system for reporting thyroid cytopathology: a single-center experience over 5 years.
    Kiernan CM; Broome JT; Solórzano CC
    Ann Surg Oncol; 2014 Oct; 21(11):3522-7. PubMed ID: 24796967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A nomogram for predicting malignancy in thyroid nodules diagnosed as atypia of undetermined significance/follicular lesions of undetermined significance on fine needle aspiration.
    Yoon JH; Lee HS; Kim EK; Moon HJ; Kwak JY
    Surgery; 2014 Jun; 155(6):1006-13. PubMed ID: 24630147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malignancy is associated with microcalcification and higher AP/T ratio in ultrasonography, but not with Hashimoto's thyroiditis in histopathology in patients with thyroid nodules evaluated as Bethesda Category III (AUS/FLUS) in cytology.
    Topaloglu O; Baser H; Cuhaci FN; Sungu N; Yalcin A; Ersoy R; Cakir B
    Endocrine; 2016 Oct; 54(1):156-168. PubMed ID: 27172917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic Lymphocytic Thyroiditis May Limit the Utility of Molecular Testing in AUS/FLUS Thyroid Nodules.
    Remer LF; Linhares SM; Scola WH; Lew JI
    J Surg Res; 2023 Sep; 289():229-233. PubMed ID: 37148856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic accuracy of Thyroid Imaging Reporting and Data System in the prediction of malignancy in nodules with atypia and follicular lesion of undetermined significance cytologies.
    Baser H; Cakir B; Topaloglu O; Alkan A; Polat SB; Dogan HT; Yazicioğlu MO; Aydin C; Ersoy R
    Clin Endocrinol (Oxf); 2017 Apr; 86(4):584-590. PubMed ID: 27911001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of atypia/follicular lesion of undetermined significance and repeat fine-needle aspiration: 5 years before and after implementation of the Bethesda System.
    Sullivan PS; Hirschowitz SL; Fung PC; Apple SK
    Cancer Cytopathol; 2014 Dec; 122(12):866-72. PubMed ID: 25078420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. American College of Radiology thyroid imaging report and data system combined with K-RAS mutation improves the management of cytologically indeterminate thyroid nodules.
    Wu H; Zhang B; Cai G; Li J; Gu X
    PLoS One; 2019; 14(7):e0219383. PubMed ID: 31295281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The predictive value of hematologic parameters in the risk of thyroid malignancy in cases with atypia/follicular lesion of undetermined significance.
    Bostan H; Sencar ME; Calapkulu M; Hepsen S; Akhanli P; Duger H; Ucan B; Kizilgul M; Ozturk Unsal I; Ozbek M; Cakal E
    Eur Arch Otorhinolaryngol; 2022 Aug; 279(8):4077-4084. PubMed ID: 35006341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.